Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial-Reference-Cited by-同舟云学术

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial

Published:2018-05-25 Issue:2 Volume:11 Page:65-71
ISSN:2005-940X
Container-title:Journal of Movement Disorders
language:en
Short-container-title:JMD

Author:

Kim Aryun,Kim Young Eun,Yun Ji Young,Kim Han-Joon,Yang Hui-Jun,Lee Woong-Woo,Shin Chae Won,Park Hyeyoung,Jung Yu Jin,Kim Ahro,Kim Yoon,Jang Mihee,Jeon Beomseok

Funder

Seoul National University Hospital

Publisher

The Korean Movement Disorder Society

Subject

Neurology (clinical),Neurology

Link

http://e-jmd.org/upload/jmd-18005.pdf

Reference24 articles.

1. Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

2. Age of Parkinson's disease onset as a predictor for the development of dyskinesia

3. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

4. A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring causal effects of sarcopenia on risk and progression of Parkinson disease by Mendelian randomization;npj Parkinson's Disease;2024-08-28

2. Role of Gut Microbiota in Neuroinflammation and Neurological Disorders;Frontiers in Clinical Drug Research - CNS and Neurological Disorders;2024-03-10

3. Polypharmazie bei der Behandlung von Parkinsonsymptomen: eine Nutzen-Risiko Abwägung;DGNeurologie;2023-10-24

4. Investigation of the Long-Term Effects of Amantadine Use in Parkinson’s Disease;Journal of Movement Disorders;2023-05-31

5. Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat;European Journal of Pharmacology;2022-08